SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-266162
Filing Date
2023-10-30
Accepted
2023-10-30 16:05:55
Documents
13
Period of Report
2023-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d576451d8k.htm   iXBRL 8-K 30783
2 EX-99.1 d576451dex991.htm EX-99.1 8879
  Complete submission text file 0001193125-23-266162.txt   164127

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA me-20231027.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20231027_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20231027_pre.xml EX-101.PRE 10812
7 EXTRACTED XBRL INSTANCE DOCUMENT d576451d8k_htm.xml XML 3252
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 231360217
SIC: 2834 Pharmaceutical Preparations